We are delighted to announce a strategic partnership between elderbrook solutions GmbH and Forschungsdock CRO GmbH, a company likewise specialized in clinical research.

This collaboration brings together complementary strengths to create greater value for sponsors across the pharmaceutical and medical technology sectors. While elderbrook contributes its comprehensive expertise in Biometrics and Clinical Data Science (BCDS), Forschungsdock CRO assumes responsibility for holistic study management from study planning and risk assessment to submissions to ethics committees and regulatory authorities, as well as the selection, coordination, and oversight of trial sites.

The shared objective of this partnership is to deliver integrated and efficient solutions across key phases of clinical development. By closely interlinking advanced data expertise with operational excellence in study execution, we aim to further enhance the quality, speed, and cost efficiency of clinical trials.

Both organizations will benefit from expanded capacities, harmonized processes, and an extended service portfolio for national and international projects. Looking ahead, we intend to continuously strengthen our collaboration and jointly develop innovative study concepts to meet evolving demands in clinical research.